{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03530",
      "entity_text" : "Sivelestat",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Sivelestat is a specific NE inhibitor first synthesized by Kawabata et al in 1991, and has been reported to attenuate pulmonary inflammation and fibrosis in animal models.",
  "reading_complete" : "2020-08-03T16:10:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:09:50Z",
  "trigger" : "attenuate",
  "evidence" : [ "Sivelestat is a specific NE inhibitor first synthesized by Kawabata et al in 1991              , and has been reported to attenuate pulmonary inflammation" ],
  "pmc_id" : "4990314",
  "score" : 0
}